Ongoing clinical trials
NCT06855706 (Recruiting): An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study.
To learn more about this trial, please contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG.
Upcoming clinical trials
A Phase I/II study to investigate the safety, biologic and anti-tumor activity of oncolytic vaccinia virus armed with a CXCR4 antagonist in combination with pembrolizumab in patients receiving liposomal doxorubicin for recurrent or treatment refractory ovarian, fallopian tube or primary peritoneal cancer (expected mid-2025).
View a list of all ovarian cancer clinical trials offered by cancer centers across the United States.